OCT 26, 2017 8:11 AM PDT

Bacterial Species Found to Promote Colorectal Cancer and Chemotherapy Resistance

WRITTEN BY: Sarah Hertrich

According to the American Cancer Society, colorectal cancer (CRC) is characterized by the unchecked division and survival of abnormal cells in the colon or rectum. The area of the intestines that make up the colon and the rectum are often referred to as the large intestine which functions to process food for energy and rid the body of solid waste.

Recent studies have shown that specific bacterial species, including Streptococcus gallolyticus and Fusobacterium nucleatum, have an effect on the outcome of colorectal cancer disease and treatment. Credit: Media & Lifestyle

CRC typically begins with the growth of a noncancerous polyp on the lining of the colon or rectum. This polyp, if not removed, will continue to grow slowly over a period of 10 or 20 years. It could then develop into an adenomatous polyp, which has less than a 10% chance to develop into an invasive cancer. However; as the adenoma becomes larger, the likelihood of it turning into cancerous cells increases. Cancer which arises from the inner lining of the colorectum is known as adenocarcinoma and accounts from approximately 96% of all CRCs.

A mounting body of evidence suggests that microbes play a role in the outcome of CRC disease as well as potential treatments, including chemotherapy. According to a study published in PLoS Pathogens, scientists identified a specific species of bacteria known as Streptococcus gallolyticus, which can support the growth of colorectal tumors, depending on cell context, bacterial growth phase, and direct contact between bacteria and colon cancer cells.

In an animal model study, mice that were inoculated with Streptococcus gallolyticus, had significantly more tumors, higher tumor burden, higher dysplasia grade, and increased cell proliferation compared to mice in control groups inoculated with other species of bacteria. In humans, authors found that Streptococcus gallolyticus was found to be present in the majority of CFC patients. Interestingly, bacterial populations were found to be higher in tumor associated tissues compared to normal tissue samples that were taken from CRC patients.

In another study published in Cell, a bacterium identified as Fusobacterium nucleatum was found to be associated with chemoresistance in CRC patients. In human cohort studies, scientists found the bacteria was highly associated with patients experiencing cancer recurrence after chemotherapy treatment. In animal model studies, scientists found that Fusobacterium nucleatum has the ability to induce cell autophagy through the dysregulation of microRNA which results in tumor chemoresistance.

The results of these two studies suggest new targets for the clinical treatment of CRC. Targeting the specific actions of these two microbes which induce tumor growth and chemoresistance could provide alternative treatments to increase CRC patient prognosis.

Sources: American Cancer Society, Microcosm Magazine, PLoS Pathogens, Cell

About the Author
  • I am a postdoctoral researcher with interests in pre-harvest microbial food safety, nonthermal food processing technologies, zoonotic pathogens, and plant-microbe interactions. My current research projects involve the optimization of novel food processing technologies to reduce the number of foodborne pathogens on fresh produce. I am a food geek!
You May Also Like
MAR 25, 2020
Clinical & Molecular DX
MAR 25, 2020
A coronavirus testing kit with glow-in-the-dark Mango?
A group of Canadian researchers is responding to a desperate need for COVID-19 diagnostic kits with their fluorescent im ...
MAR 26, 2020
Microbiology
MAR 26, 2020
US Now Leads the World in Coronavirus Cases
In the United States, there have been 83,836 confirmed cases of COVID-19, and over 529,000 worldwide.
APR 01, 2020
Clinical & Molecular DX
APR 01, 2020
One dollar kit diagnoses COVID-19 in 10 minutes
Researchers have begun efficacy testing for a new SARS-CoV-2 diagnostic kit that claims to be able to test for COVID-19 ...
MAR 31, 2020
Microbiology
MAR 31, 2020
Researchers Suggest Repurposing Pancreatitis Drug to Treat COVID-19
As SARS-CoV-2 upends normalcy in the world, researchers are trying to find a treatment for the illness it causes.
APR 16, 2020
Microbiology
APR 16, 2020
How Many COVID-19 Cases Have There Really Been?
It's widely accepted that we don't have a good idea of how many COVID-19 cases are circulating, so researchers are using ...
MAY 10, 2020
Cell & Molecular Biology
MAY 10, 2020
RNA Structure Informs RNA Function
Proteins carry out many of an organism's critical functions, and they are coded for by genes. To make a protein from ...
Loading Comments...